# Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

> **NCT00726245** · PHASE2,PHASE3 · COMPLETED · sponsor: **Meir Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Muscle Tear

## Interventions

- **BIOLOGICAL:** PRGF
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00726245
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-02
- **Final completion:** 2011-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726245, "Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00726245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*